Abstract
The asthma animal model is still the only system that is available for modelling in vivo processes of human disease since for obvious ethical reasons these experiments are not possible in humans. However, there is a marked discrepancy between numerous successful studies in animals and very few rather disappointing clinical trials in patients. The current available models are usually uniform models of an acute asthmatic attack in adult animals, which do not spontaneously develop asthma. Major anatomical differences exist between human and animal airways and comparable lung function measurements are very difficult or impossible. The main reason why simplistic animal models may be inadequate lies probably in the diversity that exists within the different phenotypes of human asthma. Whereas progress is made to develop chronic asthma models with signs of airway remodelling, severe asthma and the role of small airways is still poorly reflected in current animal models.
Keywords: Animal model, asthma, severe asthma, small airways, airway remodelling
Current Drug Targets
Title: Animal Models for Human Asthma: The Perspective of a Clinician
Volume: 9 Issue: 6
Author(s): Norbert Krug and Klaus F. Rabe
Affiliation:
Keywords: Animal model, asthma, severe asthma, small airways, airway remodelling
Abstract: The asthma animal model is still the only system that is available for modelling in vivo processes of human disease since for obvious ethical reasons these experiments are not possible in humans. However, there is a marked discrepancy between numerous successful studies in animals and very few rather disappointing clinical trials in patients. The current available models are usually uniform models of an acute asthmatic attack in adult animals, which do not spontaneously develop asthma. Major anatomical differences exist between human and animal airways and comparable lung function measurements are very difficult or impossible. The main reason why simplistic animal models may be inadequate lies probably in the diversity that exists within the different phenotypes of human asthma. Whereas progress is made to develop chronic asthma models with signs of airway remodelling, severe asthma and the role of small airways is still poorly reflected in current animal models.
Export Options
About this article
Cite this article as:
Krug Norbert and Rabe F. Klaus, Animal Models for Human Asthma: The Perspective of a Clinician, Current Drug Targets 2008; 9 (6) . https://dx.doi.org/10.2174/138945008784533598
DOI https://dx.doi.org/10.2174/138945008784533598 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Balancing Act between Colonisers and Inflammation: T regulatory and TH17 Cells in Mucosal Immunity during Otitis Media
Current Immunology Reviews (Discontinued) The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Current Topics in Medicinal Chemistry Immunomodulating Properties of Macrolides: Animal and Human Studies
Current Medicinal Chemistry - Anti-Infective Agents S1P Regulation of Macrophage Functions in the Context of Cancer
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Interference With Protein-protein Interactions of Akinase Anchoring Proteins as a Strategy for the Treatment of Disease
Current Drug Targets Availability of Oral Formulations Labeled for Use in Young Children in Serbia, Germany and the USA
Current Pharmaceutical Design Relevance of the Deletion Polymorphisms of the Glutathione S-Transferases GSTT1 and GSTM1 in Pharmacology and Toxicology
Current Drug Metabolism Clinical Considerations in Developing Dendritic Cell Vaccine Based Immunotherapy Protocols in Cancer
Current Molecular Medicine Therapeutic Implications of Beta-Adrenergic Receptor Pharmacodynamic Properties
Current Clinical Pharmacology Polymeric Carrier Systems for siRNA Delivery
Current Topics in Medicinal Chemistry Platelets and Vascular Risk: An Option for Treatment
Current Pharmaceutical Design Tryptophan Catabolism in IDO+ Plasmacytoid Dendritic Cells
Current Drug Metabolism Cognitive - Behavioral Therapy in Central Sensitivity Syndromes
Current Rheumatology Reviews The Patents on Glucocorticosteroids and Selected New Therapies for the Management of Asthma in Children: Update
Recent Patents on Inflammation & Allergy Drug Discovery Selenium Compounds Biotransformed by Mushrooms: Not Only Dietary Sources, But Also Toxicity Mediators
Current Nutrition & Food Science Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Structure-Activity Relationship Studies on ADAM Protein-Integrin Interactions
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacological Screening of Lantana camara for its Antiallergic Activity in Rodents
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Raman Spectroscopy-based Metabonomics of HIV-infected Sera Detects Amino Acid and Glutathione Changes
Current Metabolomics